IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $750,572 | +32.3% | 16,547 | +10.2% | 0.09% | -33.8% |
Q4 2022 | $567,230 | +35.7% | 15,018 | +32.9% | 0.14% | +21.4% |
Q2 2022 | $418,000 | -20.8% | 11,299 | -34.9% | 0.11% | -38.1% |
Q4 2021 | $528,000 | -20.8% | 17,346 | -12.8% | 0.18% | -16.6% |
Q3 2021 | $667,000 | -32.3% | 19,896 | +22.0% | 0.22% | -28.1% |
Q4 2019 | $985,000 | +169.9% | 16,311 | +187.1% | 0.30% | +81.9% |
Q2 2019 | $365,000 | +18.5% | 5,681 | -6.2% | 0.17% | -42.0% |
Q2 2017 | $308,000 | – | 6,059 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |